Fundz

MOMA Therapeutics Appoints Jullian G. Jones as Chief Business Officer

PRIVATEMar 11, 2024

Position

Chief Business Officer

Company

Moma Therapeutics

Jullian G. Jones
jjones@momatx.com
CambridgeBiotechnologyHealth CareScience And Engineering

Description

MOMA Therapeutics appoints Jullian G. Jones, Ph.D., J.D., MBA as the company’s chief business officer

Quick answer

MOMA Therapeutics Appoints Jullian G. Jones as Chief Business Officer (March 11, 2024). Moma Therapeutics is based in Cambridge, Massachusetts, United States.

Who is the new Chief Business Officer at Moma Therapeutics?
Moma Therapeutics named Jullian G. Jones Chief Business Officer, announced March 11, 2024.
What did Moma Therapeutics announce on March 11, 2024?
MOMA Therapeutics appoints Jullian G. Jones, Ph.D., J.D., MBA as the company’s chief business officer
What does Moma Therapeutics do?
MOMA Therapeutics is committed to discovering the next generation of precision medicines by targeting molecular machines that underlie human disease.
Where is Moma Therapeutics based?
Moma Therapeutics is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
MedinCell (March 13, 2024), Koneksa Health (March 4, 2024), Mythic Therapeutics (March 28, 2024) and Zephyr AI, Inc. (April 2, 2024) also announced leadership changes within 45 days of Moma Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Moma Therapeutics, and when

A new leader at Moma Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Moma Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Moma Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Moma Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Moma Therapeutics

Location

Cambridge, Massachusetts, United States

About

MOMA Therapeutics is committed to discovering the next generation of precision medicines by targeting molecular machines that underlie human disease. Bringing together seminal scientific advancements in biochemistry, biophysics, structural biology, chemistry and functional genomics, the company is establishing a platform to exploit a key vulnerability inherent to all enzymes in the class: their dependence on well-coordinated, stepwise changes in protein conformation. By focusing this platform on disease-causing targets, MOMA aims to develop high impact, precision medicines for patients with unmet medical needs. MOMA Therapeutics is a private company launched in 2020 and is financed by world-class biotech investors, including a prestigious group of life sciences investors.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Moma Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jullian
Likely contact at this company
••••••••@••••••••

See Jullian's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Moma Therapeutics's next move

Learn about Strategic plan

Moma Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.